| 2019新型冠状病毒肺炎治疗研究现状 |
| |
| 引用本文： | 朱耐伟,赵平,戚中田. 2019新型冠状病毒肺炎治疗研究现状[J]. 中华微生物学和免疫学杂志, 2020, 0(1): 7-10 |
| |
| 作者姓名： | 朱耐伟 赵平 戚中田 |
| |
| 作者单位： | 海军军医大学生物医学防护教研室 |
| |
| 基金项目： | 国家传染病重大专项课题(2017ZX10304403-003)。 |
| |
| 摘 要： | 2019新型冠状病毒(2019 novel coronavirus,2019-nCoV)是继严重急性呼吸综合征冠状病毒(severe acute respiratory syndrome-coronavirus,SARS-CoV)和中东呼吸综合征冠状病毒(middle east respiratory syndrome-coronavirus,MERS-CoV)后出现的一种能引起人严重呼吸道疾病的新型冠状病毒。目前尚无特异性的靶向2019-nCoV的抗病毒治疗药物,面对新型冠状病毒肺炎日益严重的疫情和迫切需要解决的药物治疗策略,本文对新型冠状病毒肺炎抗病毒治疗研究现状与进展进行综述。
|
| 关 键 词： | 2019新型冠状病毒 治疗 药物 |
Current status of treatment for 2019 novel coronavirus pneumonia |
| |
| Zhu Naiwei,Zhao Ping,Qi Zhongtian. Current status of treatment for 2019 novel coronavirus pneumonia[J]. Chinese Journal of Microbiology and Immunology, 2020, 0(1): 7-10 |
| |
| Authors: | Zhu Naiwei Zhao Ping Qi Zhongtian |
| |
| Affiliation: | (Department of Biomedical Defense,PLA Key Laboratory of Biodetection and Biodefense,Shanghai Key Laboratory of Medical Biodefense,Naval Medical University,Shanghai 200433,China) |
| |
| Abstract: | 2019 novel coronavirus(2019-nCoV)is a new member of coronavirus family that can cause serious respiratory diseases after the emergence of severe acute respiratory syndrome-coronavirus(SARS-CoV)and middle east respiratory syndrome-coronavirus(MERS-CoV).At present,there is no specific antiviral drug targeting 2019-nCoV.In facing of the increasingly serious epidemic of 2019-nCoV pneumonia and the urgent needs in drug treatment strategies,this paper reviewed the current research situation and progress in antiviral treatment for the newly identified disease. |
| |
| Keywords: | 2019 novel coronavirus Treatment Drugs |
| 本文献已被 维普 等数据库收录！ |
|
